Brands
Emami moves to acquire majority stake in Axiom Ayurveda in phased deal
First tranche lifts stake to subsidiary status, full buyout set by June
MUMBAI: Emami Limited has taken a decisive step to strengthen its play in the ayurveda segment, entering into a share purchase agreement to acquire a majority stake in Axiom Ayurveda Private Limited.
The company, which already held about 26.5 per cent in Axiom Ayurveda, is now set to raise its stake to around 73.5 per cent through the transaction. In the first tranche completed on 1 April, Emami acquired roughly 36.7 per cent equity, taking its total holding past the majority mark and turning Axiom Ayurveda into its subsidiary.
The remaining stake, comprising an equal portion, is expected to be acquired by June 2026, in line with the terms agreed under the share purchase agreement.
While financial details of the transaction were not reiterated in the latest filing, the move signals Emami’s intent to deepen its presence in the fast-growing ayurvedic and natural products space, where consumer demand continues to rise.
In a regulatory communication, Emami Limited company secretary and compliance officer Ravi Varma confirmed the completion of the first tranche and outlined the timeline for the remaining acquisition.
With Axiom Ayurveda now under its wing, Emami appears to be doubling down on traditional wellness with a modern twist, positioning itself to tap into both domestic demand and evolving global interest in ayurvedic products.
